AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
AMGEN INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$424.94−7.55 (-1.75%)
Close on Oct 19, 2026
- Market cap
- $231.17B
- P/E (TTM)
- 26.4
- Dividend yield
- 2.27%
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Nov 22, 1999 | 2-for-1 | Earlier per-share figures divided by 2 |
| Mar 1, 1999 | 2-for-1 | Earlier per-share figures divided by 2 |
| Aug 16, 1995 | 2-for-1 | Earlier per-share figures divided by 2 |
| Sep 11, 1991 | 3-for-1 | Earlier per-share figures divided by 3 |
| Aug 13, 1990 | 2-for-1 | Earlier per-share figures divided by 2 |